Moises Chica, MD
Retina Specialist · San Antonio, TXNPI 1245212232
Payments from drug & device makers
Across 194 payments — averaging $329.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ANI Pharmaceuticals, Inc.$23K
- Alimera Sciences, Inc.$19K
- US Retina LLC$12K
- AbbVie$3K
- Genentech USA, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$758
- plus $5K from 21 others
Across 19 payments — averaging $2774.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alimera Sciences, Inc.$53K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 9 | $22,946 |
| Alimera Sciences, Inc. | 36 | $19,467 |
| US Retina LLC | 11 | $11,635 |
| AbbVie(2 entities) | 28 | $2,777 |
| Genentech USA, Inc. | 17 | $1,217 |
| Regeneron Healthcare Solutions, Inc. | 18 | $758 |
| Astellas Pharma US Inc | 16 | $723 |
| Alcon | 6 | $698 |
| Regeneron | 7 | $659 |
| Apellis Pharmaceuticals, Inc. | 11 | $533 |
| Harrow Eye, LLC | 2 | $426 |
| Biotissue Holdings Inc. | 2 | $300 |
| Novartis | 4 | $203 |
| Biogen | 8 | $194 |
| Dutch Ophthalmic, USA | 2 | $157 |
| Eyepoint US, Inc. | 2 | $138 |
| Eyevance Pharmaceuticals LLC | 1 | $125 |
| Amgen | 1 | $122 |
| Optovue, Inc. | 1 | $120 |
| Ocular Therapeutix, Inc. | 1 | $118 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $118 |
| Rxsight Inc | 1 | $101 |
| Aerie Pharmaceuticals, Inc. | 1 | $98 |
| Coherus Oncology, Inc. | 2 | $64 |
| Notal Vision, Inc. | 1 | $56 |
| Bausch & Lomb Americas Inc. | 2 | $47 |
| Mallinckrodt Hospital Products Inc. | 2 | $42 |
How this compares
$63,842 in reported general payments places this provider in the 80th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in San Antonio
- Richard LaneSan Antonio$4.7M
- Sarah HolySan Antonio$689K
- Timothy ClelandSan Antonio$534K
- Enchun LiuSan Antonio$99K
- Dianne BarrettSan Antonio$48K
- Duncan FriedmanSan Antonio$9K
- Thomas OeiSan Antonio$9K
- Lina MaroufSan Antonio$4K
- Abumere AkinwaleSan Antonio$3K
- Rushil RaoSan Antonio$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.